Biofer chewable tablets, No. 30
Expiration Date: 05/2027
Russian Pharmacy name:
Биофер таблетки жевательные, №30
Treatment of latent and clinically significant iron deficiency anemia;
prevention of folic acid and iron deficiency, including the period before, during and after pregnancy, the period of breastfeeding.
The tablets are taken orally during or immediately after a meal, swallowing whole or chewing.
The dose of the drug and the duration of administration is prescribed by the doctor based on the individual severity of iron deficiency.
The daily dose can be taken once.
Recommended dosage for the treatment of iron deficiency anemia:
patients over 12 years old, women during breastfeeding: 1 pc. 1-3 times a day.
To restore the level of hemoglobin in the blood to normal, usually requires a course of treatment from 3 to 5 months.
Then you should continue taking in a dose of 1 pc. per day for several months to replenish the iron supply in the body;
Pregnancy period: 1 pc. 2-3 times a day until the normalization of hemoglobin levels in the blood.
Then, to restore iron stores, the intake is continued at a dose of 1 pc. per day, usually before delivery.
Prevention of folic acid and iron deficiency and treatment of the latent form of iron deficiency are recommended in a dose of 1 pc. per day.
Latent iron deficiency therapy should be continued for 1-2 months
1 chewable tablet contains:
active ingredients:
iron (III) hydroxide polymaltose - 318.2 mg (equivalent to 100 mg of iron),
folic acid - 0.35 mg;
auxiliary components:
caramel, lactose monohydrate, colloidal silicon dioxide, magnesium stearate, sodium chloride, mannitol, chocolate flavor, sodium methyl parahydroxybenzoate, aspartame, sodium propyl parahydroxybenzoate, vanilla flavor, purified talc, purified water.
Hemochromatosis (excess iron in the body);
anemia not associated with iron deficiency (hemolytic anemia, megaloblastic anemia caused by a lack of vitamin B12);
violation of iron utilization (lead anemia, sideroachrestic anemia, thalassemia);
age up to 12 years.
Carefully:
It is not recommended to prescribe Biofer to patients with gastric ulcer and duodenal ulcer,
inflammatory pathologies of the gastrointestinal tract (GIT).
In the first trimester of pregnancy, use is indicated only in case of acute need, provided that the benefits to the mother from therapy are much higher than the possible risk to the fetus.
When breastfeeding, taking the drug is allowed only for clinical indications.
Chewable tablets, dark brown in color, round, with a score line on one side; the presence of inclusions of a darker color is allowed.
Composition:
1 chewable tablet contains:
active ingredients:
iron (III) hydroxide polymaltose - 318.2 mg (equivalent to 100 mg of iron),
folic acid - 0.35 mg;
auxiliary components:
caramel, lactose monohydrate, colloidal silicon dioxide, magnesium stearate, sodium chloride, mannitol, chocolate flavor, sodium methyl parahydroxybenzoate, aspartame, sodium propyl parahydroxybenzoate, vanilla flavor, purified talc, purified water.
Indications for use:
Treatment of latent and clinically significant iron deficiency anemia;
prevention of folic acid and iron deficiency, including the period before, during and after pregnancy, the period of breastfeeding.
Contraindications:
Hemochromatosis (excess iron in the body);
anemia not associated with iron deficiency (hemolytic anemia, megaloblastic anemia caused by a lack of vitamin B12);
violation of iron utilization (lead anemia, sideroachrestic anemia, thalassemia);
age up to 12 years.
Carefully:
It is not recommended to prescribe Biofer to patients with gastric ulcer and duodenal ulcer,
inflammatory pathologies of the gastrointestinal tract (GIT).
In the first trimester of pregnancy, use is indicated only in case of acute need, provided that the benefits to the mother from therapy are much higher than the possible risk to the fetus.
When breastfeeding, taking the drug is allowed only for clinical indications.
Method of administration and dosage:
The tablets are taken orally during or immediately after a meal, swallowing whole or chewing.
The dose of the drug and the duration of administration is prescribed by the doctor based on the individual severity of iron deficiency.
The daily dose can be taken once.
Recommended dosage for the treatment of iron deficiency anemia:
patients over 12 years old, women during breastfeeding: 1 pc. 1-3 times a day.
To restore the level of hemoglobin in the blood to normal, usually requires a course of treatment from 3 to 5 months.
Then you should continue taking in a dose of 1 pc. per day for several months to replenish the iron supply in the body;
Pregnancy period: 1 pc. 2-3 times a day until the normalization of hemoglobin levels in the blood.
Then, to restore iron stores, the intake is continued at a dose of 1 pc. per day, usually before delivery.
Prevention of folic acid and iron deficiency and treatment of the latent form of iron deficiency are recommended in a dose of 1 pc. per day.
Latent iron deficiency therapy should be continued for 1-2 months
Side effects:
Digestive system: very rarely - constipation or diarrhea, nausea, a feeling of fullness in the gastrointestinal tract and pressure in the epigastric region;
possibly - staining of feces in a dark color;
others: very rarely - the development of allergic reactions to folic acid.
Special instructions:
Patients with diabetes should take into account that 1 tablet contains 0.06 XE (bread units).
The dark color of the feces is due to the presence of non-absorbed iron, therefore, should not cause concerns about the patient's clinical condition.
Drug interactions:
The interaction of Biofer with other drugs has not been established.
Terms and conditions of storage:
Keep out of the reach of children.
Store in a place protected from moisture and light at temperatures up to 25 ? C.
Shelf life is 3 years.